BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,085 | +0.7% | 1,989 | 0.0% | 0.01% | +7.7% |
| Q2 2023 | $214,673 | -13.4% | 1,989 | 0.0% | 0.01% | -18.8% |
| Q1 2023 | $247,770 | -17.1% | 1,989 | 0.0% | 0.02% | -20.0% |
| Q4 2022 | $298,788 | +11.5% | 1,989 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $268,000 | -9.8% | 1,989 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $297,000 | -11.1% | 1,989 | +1.7% | 0.02% | +10.5% |
| Q1 2022 | $334,000 | -83.7% | 1,956 | -75.3% | 0.02% | -84.6% |
| Q4 2021 | $2,043,000 | -18.4% | 7,925 | -13.6% | 0.12% | -26.3% |
| Q3 2021 | $2,505,000 | +41.7% | 9,175 | +16.2% | 0.17% | +40.3% |
| Q2 2021 | $1,768,000 | +16.5% | 7,895 | -43.2% | 0.12% | +2.6% |
| Q1 2021 | $1,517,000 | +70.6% | 13,895 | +27.5% | 0.12% | +58.9% |
| Q4 2020 | $889,000 | +54.9% | 10,895 | +32.5% | 0.07% | +40.4% |
| Q3 2020 | $574,000 | +177.3% | 8,223 | +164.6% | 0.05% | +160.0% |
| Q2 2020 | $207,000 | – | 3,108 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |